durvalumab,medi1191
Astrazeneca
['durva', 'medi1191']
#cedarssinaicancer at #aacr23. dr. inderjit mehmi is co-author &amp; dr. omid hamid is senior author on intratumoral medi1191 + durvalumab: update on the first-in-human study in advanced solid #tumors presented at 11:15am pt. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.